Over the several years of researching anything to do with Brainchip and its AKIDA technology it became apparent that Singapore was in some way involved. This view was of course reinforced by the former CEO Mr. Dinardo who mention Singapore, Quantum, Brainchip and IOT Smart City in one breath.
Every now and then I have a look and just now I found the following which sounds just like AKD1000:
“Energy efficient ECG classification with spiking neural network☆
Author links open overlay panel
ZhangluYanWeng-FaiWong1
Show more
Outline
Share
Cite
https://doi.org/10.1016/j.bspc.2020.102170Get rights and content
Abstract
Heart disease is one of the top ten threats to global health in 2019 according to the WHO. Continuous monitoring of ECG on wearable devices can detect abnormality in the user’s heartbeat early, thereby significantly increasing the chance of early intervention which is known to be the key to saving lives. In this paper, we present a set of inter-patient ECG classification methods that use convolutional (CNNs) and spiking neural networks (SNNs). We focused on inter-patient heartbeat classification, in which the model is trained over several patients and then used to infer that for patients not used in training. Raw heartbeat data is used in this paper because most wearable devices cannot deal with complex data preprocessing. A two-steps convolutional neural network testing method is proposed for saving power. For even greater energy-saving, a spiking neural network is also proposed. The latter is obtained from converting the trained CNN model with a less than one percent accuracy drop. The average power of a two-classes SNN is 0.077 W, or that of previously proposed neural network-based solutions”
Background: Wearable technology has the potential to improve cardiovascular health monitoring by using machine learning. Such technology enables remote health monitoring and allows for the diagnosis and prevention of cardiovascular diseases. In addition to the detection of cardiovascular...
medinform.jmir.org
The rest of the paper requires the payment of a fee.
If only Shane Warne had, had the benefit of such a wearable device as a routine health check at 50 years of age.
The potential for Brainchip’s technology to serve in every industry known and yet to be developed is as plain as the nose on Jimmy Durante’s face.
Investors will be greatly rewarded for their vision and fortitude in my opinion.
I remain firm in my conviction that BRNASX will be at least $2.75 by Christmas.
My opinion only DYOR
FF
AKIDA BALLISTA